Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3- O -rutinoside on heart failure
Acta Pharmaceutica · 01.03.2025 · 75 (1) · 119-132
DOI: 10.2478/acph-2025-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 10.04.2025. Verfasst von Lu-Qin Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China. Hauptthemen laut MEDLINE: Kaempferols, Heart Failure, Cardiotonic Agents, Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kaempferol-3- O -rutinoside (KR) has an excellent cardioprotective effect, but its mechanism of action is not clear. Network pharmacology was used to predict the signaling pathways, whereas molecular docking was used for preliminary validation of KR binding to targets. AMI model rats with ligated left anterior descending coronary arteries were established. HE staining was used to detect pathological changes, and ELISA was used to detect the expression of TNF-α and IL-6. Network pharmacology results showed PI3K-AKT signaling pathway may be the main mechanism, and molecular docking predicted that KR could bind strongly to the PI3K and AKT. KR could significantly reduce cardiac pathological changes, decrease the level of TNF-α and IL-6, and enhance the mRNA and protein expressions of PI3K and AKT. KR ameliorates HF after AMI by enhancing the expressions of PI3K and AKT, which will be helpful in elucidating the mechanism of KR through multiple techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China.
- 2School of Pharmacy, Anhui Xinhua University Hefei, Anhui, 230088, China.
- 3Research Institute of Integrated Traditional Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, Anhui, 230012, China.
- 4Anhui Provincial Key Laboratory of Chinese Medicinal Formula, Hefei, Anhui, 230012, China.
ORCID-Profile: Peng Zhou
Zitieren
APA
Guo, L. Q., Zhou, L., Li, S. N., Bai, J., Shi, L. L., Hua, F., & Zhou, P. (2025). Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3- O -rutinoside on heart failure. Acta Pharmaceutica, 75(1), 119-132. https://doi.org/10.2478/acph-2025-0001
Vancouver
Guo LQ, Zhou L, Li SN, Bai J, Shi LL, Hua F, et al. Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3- O -rutinoside on heart failure. Acta Pharmaceutica. 2025;75(1):119-132. doi:10.2478/acph-2025-0001
BibTeX
@article{Guo2025,
author = {Guo, Lu-Qin and Zhou, Lan and Li, Sheng-Nan and Bai, Juan and Shi, Ling-Li and Hua, Fang and Zhou, Peng},
title = {Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3- O -rutinoside on heart failure},
journal = {Acta Pharmaceutica},
year = {2025},
volume = {75},
number = {1},
pages = {119--132},
doi = {10.2478/acph-2025-0001}
}
EUVIMED